FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
LHCSX
Price
$22.61
Change
+$0.13 (+0.58%)
Updated
Nov 19 closing price
Net Assets
8.85M
Interact to see
Advertisement

FSPHX vs LHCSX

Header iconFSPHX vs LHCSX Comparison
Open Charts FSPHX vs LHCSXBanner chart's image
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
Lord Abbett Health Care R4
Price$22.61
Change+$0.13 (+0.58%)
VolumeN/A
Net Assets8.85M
FSPHX vs LHCSX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. LHCSX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and LHCSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. LHCSX (8.85M). LHCSX pays higher dividends than FSPHX: LHCSX (0.29) vs FSPHX (0.02). FSPHX was incepted earlier than LHCSX: FSPHX (44 years) vs LHCSX (6 years). LHCSX (3.34) is less costly to investors than FSPHX (0.63). LHCSX is a more actively managed with annual turnover of: 88.00 vs. FSPHX (40.00). FSPHX (0) and LHCSX (0) have matching initial minimum investment requirements. LHCSX annual gain was more profitable for investors over the last year : 14.23 vs. FSPHX (0.02). LHCSX return over 5 years is better than : 9.25 vs. FSPHX (-8.84).
FSPHXLHCSXFSPHX / LHCSX
Total Expense Ratio0.631.0361%
Annual Report Gross Expense Ratio0.633.3419%
Fund Existence44 years6 years-
Gain YTD10.53217.38961%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B8.85M70,229%
Annual Yield % from dividends0.020.296%
Returns for 1 year0.0214.230%
Returns for 3 years10.4732.0933%
Returns for 5 years-8.849.25-96%
Returns for 10 years39.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5